Filed by 17 state attorneys general, the lawsuit targets trans people by undermining a core pillar of disability rights.

The U.S. FDA has officially declared that Novo Nordisk’s (NVO) popular diabetes and weight loss therapies, Ozempic and Wegovy, are no longer in ...

CardCash.com to Offer Cost-Effective Solutions for High-Demand GLP-1 Medications as Prescription Drug Market Grows SCHAUMBURG, IL / ACCESS ...

A push to ban sugary drinks, candy and more from the Supplemental Nutrition Assistance Program may soon get a boost from new ...

Insulin resistance precedes and predicts the onset of type 2 diabetes mellitus (DM2), a chronic disease that causes high ...

Negotiations for the second phase of the Gaza ceasefire deal “will happen this week”, Israeli Foreign Minister Gideon Saar ...

The U.S. District Court for the Eastern District of Pennsylvania concluded the plaintiff, who has Type 1 diabetes and tracks ...

Rep. Rosa DeLauro warned that limiting grants from the National Institutes of Health will cause “irreparable damage.” ...

Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...

Drugmakers offer “copay assistance programs” to help people afford expensive medicines. But health insurers are milking these programs for billions of dollars in extra profits while denying patients ...

Regenics, a leading health and wellness company dedicated to optimizing human performance, is giving back to the brave men and women who risk ...

WASHINGTON — Patients who use smartphone apps to manage their diabetes could face serious health problems if they miss notifications needed to control their blood sugar, U.S. health officials ...